Remove keyword clinical-hold
article thumbnail

Prominent Reasons Behind The Failure Of NAMPT inhibitors And Key Strategies Adopted By Developers To Overcome Such Challenges

Roots Analysis

Despite their potential therapeutic benefits, NAMPT inhibitors have faced several challenges in clinical development. Several factors have contributed to the failure of NAMPT inhibitors in clinical trials, including poor pharmacokinetic properties, limited efficacy, and toxicity issues.

FDA 40